Skip to content
Home/Companies/Pharma/Ceres
Ceres

Ceres

Pharma·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Ceres?

Ceres is a French Pharma company, currently owned by Naxicap Partners since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Naxicap Partners
Investor
Naxicap Partners
NIO II · 2020 · Buyout

Key facts

HQFrance
SectorPharma
Websiteceres-pharma.com

More from NIO II

Other portfolio companies in the same fund.

Naxicap Partners
Active
FinancialsFrance· 2026
Pruis Schoentechniek & voetzorg
Pruis Schoentechniek & voetzorg
Active
ConsumerNetherlands· 2026
Somatoline
Active
ConsumerFrance· 2026
: Synchrone Groupe III
Active
Business ServicesFrance· 2025
ADDEV GROUP
Addev Group
Exited 2025
SoftwareFrance· 2025
to PETRUS CONSEIL
ADDEV MATERIALS
Addev Materials
Active
Aerospace & DefenceFrance· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Ceres?

Ceres is currently owned by Naxicap Partners, through NIO II, since 2021.

When did Naxicap Partners acquire Ceres?

Naxicap Partners acquired Ceres in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue